Dr. Shenoy is Chief of Infection Control for Mass General Brigham healthcare system. In this role, she is responsible for the development and implementation of infection control strategies, policies, and measurement across the Mass General Brigham system. She is an Associate Professor of Medicine at Harvard Medical School and an Infectious Diseases physician at Massachusetts General Hospital, where she cares for patients on the inpatient Infectious Diseases Consult Service. Dr. Shenoy is Medical Director of the Regional Emerging Special Pathogens Treatment Center at MGH, one of thirteen federally-funded centers with expertise in preparedness and response for emerging pathogens.
Dr. Shenoy a voting member of the Healthcare Infection Control Practices Advisory Committee (HICPAC) at the Centers for Disease Control and Prevention (CDC), the federal advisory committee appointed to provide advice and guidance to DHHS and CDC regarding the practice of infection control and strategies for surveillance, prevention, and control of healthcare-associated infections, antimicrobial resistance and related events in United States healthcare settings. She is a fellow of the Infectious Diseases Society of America and the Society for Healthcare Epidemiology of America (SHEA). She is currently Chair of SHEA’s Public Policy and Government Affairs Committee and co-chair of the Sterilization and High-Level Disinfection guidelines committee.
Clinical Interests:
Treats:
Languages:
Mass General Infectious Diseases
55 Fruit St.
Boston, MA 02114
Phone: 617-726-3906
Medical Education
American Board Certifications
Note: This provider may accept more insurance plans than shown; please call the practice to find out if your plan is accepted.
Dr. Shenoy?s research has evaluated the clinical, operational and economic impact of infection control strategies and prevention of healthcare-associated infections through clinical studies and mathematical modeling, use of electronic health records for surveillance, and applied machine-learning techniques. She is the Principal Investigator on a CDC-funded National Infection Prevention and Control and Improving Patient Safety in the United States cooperative agreement focused on innovation in IPC education and clinical decision support.
